Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2014 Nov 7;3(6):e001483.
doi: 10.1161/JAHA.114.001483.

Idiopathic pericarditis and pericardial effusion in children: contemporary epidemiology and management

Affiliations
Multicenter Study

Idiopathic pericarditis and pericardial effusion in children: contemporary epidemiology and management

Divya Shakti et al. J Am Heart Assoc. .

Abstract

Background: Multicenter studies on idiopathic or viral pericarditis and pericardial effusion (PPE) have not been reported in children. Colchicine use for PPE in adults is supported. We explored epidemiology and management for inpatient hospitalizations for PPE in US children and risk factors for readmission.

Methods and results: We analyzed patients in the Pediatric Health Information System database for (1) a code for PPE; (2) absence of codes for underlying systemic disease (eg, neoplastic, cardiac, rheumatologic, renal); (3) age ≥30 days and <21 years; and (4) discharge between January 1, 2007, and December 31, 2012, from 38 hospitals contributing complete data for each year of the study period. Among 11 364 hospitalizations with PPE codes during the study period, 543 (4.8%) met entry criteria for idiopathic or viral PPE. Significantly more boys were noted, especially among adolescents. No temporal trends were noted. Median age was 14.5 years (interquartile range 7.3 to 16.6 years); 78 patients (14.4%) underwent pericardiocentesis, 13 (2.4%) underwent pericardiotomy, and 11 (2.0%) underwent pericardiectomy; 157 (28.9%) had an intensive care unit stay, including 2.0% with tamponade. Median hospitalization was 3 days (interquartile range 2 to 4 days). Medications used at initial admission were nonsteroidal anti-inflammatory drugs (71.3%), corticosteroids (22.7%), aspirin (7.0%), and colchicine (3.9%). Readmissions within 1 year of initial admission occurred in 46 of 447 patients (10.3%), mostly in the first 3 months. No independent predictors of readmission were noted, but our statistical power was limited. Practice variation was noted in medical management and pericardiocentesis.

Conclusions: Our report provides the first large multicenter description of idiopathic or viral PPE in children. Idiopathic or viral PPE is most common in male adolescents and is treated infrequently with colchicine.

Keywords: colchicine; pediatric; pericardial disease; pericardial effusion; pericarditis; pericardium.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Age and sex at initial admission. *Wilcoxon rank sum test.
Figure 2.
Figure 2.
Geographic distribution at initial admission. *Chi‐square test.
Figure 3.
Figure 3.
Trends for initial admission by quarters of each year of the study period. *Chi‐square test. Q1 indicates first quarter.
Figure 4.
Figure 4.
Practice variation in management in initial admission. A, Practice variation in corticosteroid use in initial admission. B, Practice variation in colchicine use in initial admission. C, Practice variation in pericardial drainage procedure use in initial admission.
Figure 5.
Figure 5.
Time to first readmission since initial admission.

References

    1. Kuhn B, Peters J, Marx GR, Breitbart RE. Etiology, management, and outcome of pediatric pericardial effusions. Pediatr Cardiol. 2008; 29:90-94. - PubMed
    1. Mok GC, Menahem S. Large pericardial effusions of inflammatory origin in childhood. Cardiol Young. 2003; 13:131-136. - PubMed
    1. Ratnapalan S, Brown K, Benson L. Children presenting with acute pericarditis to the emergency department. Pediatr Emerg Care. 2011; 27:581-585. - PubMed
    1. Imazio M, Bobbio M, Cecchi E, Demarie D, Demichelis B, Pomari F, Moratti M, Gaschino G, Giammaria M, Ghisio A, Belli R, Trinchero R. Colchicine in addition to conventional therapy for acute pericarditis: results of the COlchicine for acute PEricarditis (COPE) trial. Circulation. 2005; 112:2012-2016. - PubMed
    1. Imazio M, Bobbio M, Cecchi E, Demarie D, Pomari F, Moratti M, Ghisio A, Belli R, Trinchero R. Colchicine as first‐choice therapy for recurrent pericarditis: results of the CORE (COlchicine for REcurrent pericarditis) trial. Arch Intern Med. 2005; 165:1987-1991. - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources